Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 31 entries
Sorted by: Best Match Show Resources per page
Correction to: Anaphylactoid Reactions to Intravenous N-Acetylcysteine during Treatment for Acetaminophen Poisoning.

Journal of medical toxicology : official journal of the American College of Medical Toxicology

Yarema M, Chopra P, Sivilotti MLA, Johnson D, Nettel-Aguirre A, Bailey B, Victorino C, Gosselin S, Purssell R, Thompson M, Spyker D, Rumack B.
PMID: 29532341
J Med Toxicol. 2018 Jun;14(2):173. doi: 10.1007/s13181-018-0657-5.

The original article has been corrected. Table 4 in PDF version of this article has been corrected since the original publication of the article because the first column of numbers (under the heading "Female") in the original PDF version...

Cite
Yarema M, Chopra P, Sivilotti MLA, et al. Correction to: Anaphylactoid Reactions to Intravenous N-Acetylcysteine during Treatment for Acetaminophen Poisoning. J Med Toxicol. 2018;14(2):173doi: 10.1007/s13181-018-0657-5.
Yarema, M., Chopra, P., Sivilotti, M. L. A., Johnson, D., Nettel-Aguirre, A., Bailey, B., Victorino, C., Gosselin, S., Purssell, R., Thompson, M., Spyker, D., & Rumack, B. (2018). Correction to: Anaphylactoid Reactions to Intravenous N-Acetylcysteine during Treatment for Acetaminophen Poisoning. Journal of medical toxicology : official journal of the American College of Medical Toxicology, 14(2), 173. https://doi.org/10.1007/s13181-018-0657-5
Yarema, Mark, et al. "Correction to: Anaphylactoid Reactions to Intravenous N-Acetylcysteine during Treatment for Acetaminophen Poisoning." Journal of medical toxicology : official journal of the American College of Medical Toxicology vol. 14,2 (2018): 173. doi: https://doi.org/10.1007/s13181-018-0657-5
Yarema M, Chopra P, Sivilotti MLA, Johnson D, Nettel-Aguirre A, Bailey B, Victorino C, Gosselin S, Purssell R, Thompson M, Spyker D, Rumack B. Correction to: Anaphylactoid Reactions to Intravenous N-Acetylcysteine during Treatment for Acetaminophen Poisoning. J Med Toxicol. 2018 Jun;14(2):173. doi: 10.1007/s13181-018-0657-5. PMID: 29532341; PMCID: PMC5962468.
Copy Download .nbib Format: NLM
Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosis.

Oncology letters

Mohr M, Schliemann C, Biermann C, Schmidt LH, Kessler T, Schmidt J, Wiebe K, Müller KM, Hoffmann TK, Groll AH, Werner C, Kessler C, Wiewrodt R, Rudack C, Berdel WE.
PMID: 25289079
Oncol Lett. 2014 Nov;8(5):1912-1918. doi: 10.3892/ol.2014.2486. Epub 2014 Aug 28.

Recurrent respiratory papillomatosis (RRP) is a primary benign disease, which is characterized by papillomatous growth in the respiratory tract. Malignant transformation occurs in only 3-5% of cases, however, local growth of the benign papillomas is interpreted as clinically malignant...

Cite
Mohr M, Schliemann C, Biermann C, et al. Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosis. Oncol Lett. 2014;8(5):1912-1918doi: 10.3892/ol.2014.2486.
Mohr, M., Schliemann, C., Biermann, C., Schmidt, L. H., Kessler, T., Schmidt, J., Wiebe, K., Müller, K. M., Hoffmann, T. K., Groll, A. H., Werner, C., Kessler, C., Wiewrodt, R., Rudack, C., & Berdel, W. E. (2014). Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosis. Oncology letters, 8(5), 1912-1918. https://doi.org/10.3892/ol.2014.2486
Mohr, Michael, et al. "Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosis." Oncology letters vol. 8,5 (2014): 1912-1918. doi: https://doi.org/10.3892/ol.2014.2486
Mohr M, Schliemann C, Biermann C, Schmidt LH, Kessler T, Schmidt J, Wiebe K, Müller KM, Hoffmann TK, Groll AH, Werner C, Kessler C, Wiewrodt R, Rudack C, Berdel WE. Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosis. Oncol Lett. 2014 Nov;8(5):1912-1918. doi: 10.3892/ol.2014.2486. Epub 2014 Aug 28. PMID: 25289079; PMCID: PMC4186578.
Copy Download .nbib Format: NLM
Comparing N-acetylcysteine and 4-methylpyrazole as antidotes for acetaminophen overdose.

Archives of toxicology

Akakpo JY, Ramachandran A, Curry SC, Rumack BH, Jaeschke H.
PMID: 34978586
Arch Toxicol. 2022 Jan 03; doi: 10.1007/s00204-021-03211-z. Epub 2022 Jan 03.

Acetaminophen (APAP) overdose can cause hepatotoxicity and even liver failure. N-acetylcysteine (NAC) is still the only FDA-approved antidote against APAP overdose 40 years after its introduction. The standard oral or intravenous dosing regimen of NAC is highly effective for...

Cite
Akakpo JY, Ramachandran A, Curry SC, et al. Comparing N-acetylcysteine and 4-methylpyrazole as antidotes for acetaminophen overdose. Arch Toxicol. 2022;doi: 10.1007/s00204-021-03211-z.
Akakpo, J. Y., Ramachandran, A., Curry, S. C., Rumack, B. H., & Jaeschke, H. (2022). Comparing N-acetylcysteine and 4-methylpyrazole as antidotes for acetaminophen overdose. Archives of toxicology, . https://doi.org/10.1007/s00204-021-03211-z
Akakpo, Jephte Y, et al. "Comparing N-acetylcysteine and 4-methylpyrazole as antidotes for acetaminophen overdose." Archives of toxicology vol. (2022). doi: https://doi.org/10.1007/s00204-021-03211-z
Akakpo JY, Ramachandran A, Curry SC, Rumack BH, Jaeschke H. Comparing N-acetylcysteine and 4-methylpyrazole as antidotes for acetaminophen overdose. Arch Toxicol. 2022 Jan 03; doi: 10.1007/s00204-021-03211-z. Epub 2022 Jan 03. PMID: 34978586.
Copy Download .nbib Format: NLM
Detecting myositis as a cause of unexplained dysphagia: Proposal for a diagnostic algorithm.

European journal of neurology

Labeit B, Grond T, Beule AG, Boehmer M, Thomas C, Muhle P, Claus I, Roderigo M, Rudack C, Wiendl H, Dziewas R, Warnecke T, Suntrup-Krueger S.
PMID: 34862828
Eur J Neurol. 2021 Dec 04; doi: 10.1111/ene.15202. Epub 2021 Dec 04.

BACKGROUND AND PURPOSE: Idiopathic inflammatory myopathy (IIM) can present with dysphagia as a leading or only symptom. In such cases, diagnostic evaluation may be difficult, especially if serological and electromyographical findings are unsuspicious. In this observational study we propose...

Cite
Labeit B, Grond T, Beule AG, et al. Detecting myositis as a cause of unexplained dysphagia: Proposal for a diagnostic algorithm. Eur J Neurol. 2021;doi: 10.1111/ene.15202.
Labeit, B., Grond, T., Beule, A. G., Boehmer, M., Thomas, C., Muhle, P., Claus, I., Roderigo, M., Rudack, C., Wiendl, H., Dziewas, R., Warnecke, T., & Suntrup-Krueger, S. (2021). Detecting myositis as a cause of unexplained dysphagia: Proposal for a diagnostic algorithm. European journal of neurology, . https://doi.org/10.1111/ene.15202
Labeit, Bendix, et al. "Detecting myositis as a cause of unexplained dysphagia: Proposal for a diagnostic algorithm." European journal of neurology vol. (2021). doi: https://doi.org/10.1111/ene.15202
Labeit B, Grond T, Beule AG, Boehmer M, Thomas C, Muhle P, Claus I, Roderigo M, Rudack C, Wiendl H, Dziewas R, Warnecke T, Suntrup-Krueger S. Detecting myositis as a cause of unexplained dysphagia: Proposal for a diagnostic algorithm. Eur J Neurol. 2021 Dec 04; doi: 10.1111/ene.15202. Epub 2021 Dec 04. PMID: 34862828.
Copy Download .nbib Format: NLM
IL-8 and IFN-γ as Preoperative Predictors of the Outcome of Tonsillectomy.

Ear, nose, & throat journal

Seethaler A, Stenner M, McNally A, Rudack C, Roth J, Vogl T, Spiekermann C.
PMID: 32182134
Ear Nose Throat J. 2021 Sep;100(5):822S-827S. doi: 10.1177/0145561320910682. Epub 2020 Mar 17.

OBJECTIVES: Tonsillectomy (TE) and tonsillotomy (TO) due to recurrent episodes of acute tonsillitis (RAT) belong to the most frequent surgical procedures. However, an adequate objective marker predicting the outcome of TE/TO preoperatively is missing.METHODS: Patients with RAT who underwent...

Cite
Seethaler A, Stenner M, McNally A, et al. IL-8 and IFN-γ as Preoperative Predictors of the Outcome of Tonsillectomy. Ear Nose Throat J. 2020;100(5):822S-827Sdoi: 10.1177/0145561320910682.
Seethaler, A., Stenner, M., McNally, A., Rudack, C., Roth, J., Vogl, T., & Spiekermann, C. (2021). IL-8 and IFN-γ as Preoperative Predictors of the Outcome of Tonsillectomy. Ear, nose, & throat journal, 100(5), 822S-827S. https://doi.org/10.1177/0145561320910682
Seethaler, Alicia, et al. "IL-8 and IFN-γ as Preoperative Predictors of the Outcome of Tonsillectomy." Ear, nose, & throat journal vol. 100,5 (2021): 822S-827S. doi: https://doi.org/10.1177/0145561320910682
Seethaler A, Stenner M, McNally A, Rudack C, Roth J, Vogl T, Spiekermann C. IL-8 and IFN-γ as Preoperative Predictors of the Outcome of Tonsillectomy. Ear Nose Throat J. 2021 Sep;100(5):822S-827S. doi: 10.1177/0145561320910682. Epub 2020 Mar 17. PMID: 32182134.
Copy Download .nbib Format: NLM
Fomepizole as an adjunct in acetylcysteine treated acetaminophen overdose patients: a case series.

Clinical toxicology (Philadelphia, Pa.)

Link SL, Rampon G, Osmon S, Scalzo AJ, Rumack BH.
PMID: 34709101
Clin Toxicol (Phila). 2021 Oct 28;1-6. doi: 10.1080/15563650.2021.1996591. Epub 2021 Oct 28.

INTRODUCTION: Acetaminophen (N-acetyl-para-aminophenol or APAP) is the leading cause of acute liver failure worldwide. Standard therapy for APAP overdose is with IV N-acetylcysteine (NAC). However, overdose patients treated with NAC can still incur hepatotoxicity in some circumstances. Fomepizole has...

Cite
Link SL, Rampon G, Osmon S, et al. Fomepizole as an adjunct in acetylcysteine treated acetaminophen overdose patients: a case series. Clin Toxicol (Phila). 2021;1-6doi: 10.1080/15563650.2021.1996591.
Link, S. L., Rampon, G., Osmon, S., Scalzo, A. J., & Rumack, B. H. (2021). Fomepizole as an adjunct in acetylcysteine treated acetaminophen overdose patients: a case series. Clinical toxicology (Philadelphia, Pa.), 1-6. https://doi.org/10.1080/15563650.2021.1996591
Link, Stephanie L, et al. "Fomepizole as an adjunct in acetylcysteine treated acetaminophen overdose patients: a case series." Clinical toxicology (Philadelphia, Pa.) vol. (2021): 1-6. doi: https://doi.org/10.1080/15563650.2021.1996591
Link SL, Rampon G, Osmon S, Scalzo AJ, Rumack BH. Fomepizole as an adjunct in acetylcysteine treated acetaminophen overdose patients: a case series. Clin Toxicol (Phila). 2021 Oct 28;1-6. doi: 10.1080/15563650.2021.1996591. Epub 2021 Oct 28. PMID: 34709101.
Copy Download .nbib Format: NLM
Reply to Comments on Fomepizole as an adjunct in acetylcysteine treated acetaminophen overdose patients: a case series.

Clinical toxicology (Philadelphia, Pa.)

Link SL, Rampon G, Osmon S, Scalzo AJ, Rumack BH.
PMID: 34937467
Clin Toxicol (Phila). 2021 Dec 23;1-3. doi: 10.1080/15563650.2021.2016799. Epub 2021 Dec 23.

No abstract available.

Cite
Link SL, Rampon G, Osmon S, et al. Reply to Comments on Fomepizole as an adjunct in acetylcysteine treated acetaminophen overdose patients: a case series. Clin Toxicol (Phila). 2021;1-3doi: 10.1080/15563650.2021.2016799.
Link, S. L., Rampon, G., Osmon, S., Scalzo, A. J., & Rumack, B. H. (2021). Reply to Comments on Fomepizole as an adjunct in acetylcysteine treated acetaminophen overdose patients: a case series. Clinical toxicology (Philadelphia, Pa.), 1-3. https://doi.org/10.1080/15563650.2021.2016799
Link, Stephanie L, et al. "Reply to Comments on Fomepizole as an adjunct in acetylcysteine treated acetaminophen overdose patients: a case series." Clinical toxicology (Philadelphia, Pa.) vol. (2021): 1-3. doi: https://doi.org/10.1080/15563650.2021.2016799
Link SL, Rampon G, Osmon S, Scalzo AJ, Rumack BH. Reply to Comments on Fomepizole as an adjunct in acetylcysteine treated acetaminophen overdose patients: a case series. Clin Toxicol (Phila). 2021 Dec 23;1-3. doi: 10.1080/15563650.2021.2016799. Epub 2021 Dec 23. PMID: 34937467.
Copy Download .nbib Format: NLM
Actual therapeutic management of allergic and hyperreactive nasal disorders.

GMS current topics in otorhinolaryngology, head and neck surgery

Rudack C.
PMID: 22073046
GMS Curr Top Otorhinolaryngol Head Neck Surg. 2004;3:Doc04. Epub 2004 Dec 28.

Allergic rhinitis (AR) and hyperractive disorders of the upper airways, depending upon the type of releasing stimuli, are defined as nasal hyperreactivity, for example in the case of AR, or as non-specific nasal hyperreactivity and as idiopathic rhinitis (IR)...

Cite
Rudack C. Actual therapeutic management of allergic and hyperreactive nasal disorders. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2004;3:Doc04
Rudack, C. (2004). Actual therapeutic management of allergic and hyperreactive nasal disorders. GMS current topics in otorhinolaryngology, head and neck surgery, 3Doc04.
Rudack, Claudia. "Actual therapeutic management of allergic and hyperreactive nasal disorders." GMS current topics in otorhinolaryngology, head and neck surgery vol. 3 (2004): Doc04.
Rudack C. Actual therapeutic management of allergic and hyperreactive nasal disorders. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2004;3:Doc04. Epub 2004 Dec 28. PMID: 22073046; PMCID: PMC3199794.
Copy Download .nbib Format: NLM
Diseases of the nose and paranasal sinuses in child.

GMS current topics in otorhinolaryngology, head and neck surgery

Stenner M, Rudack C.
PMID: 25587370
GMS Curr Top Otorhinolaryngol Head Neck Surg. 2014 Dec 01;13:Doc10. doi: 10.3205/cto000113. eCollection 2014.

Diseases of the pediatric nose and nasal sinuses as well as neighboring anatomical structures encompass a variety of pathologies, especially of inflammatory nature. Congenital disease, such as malformations and structural deviations of the nasal septum, as well as systemic...

Cite
Stenner M, Rudack C. Diseases of the nose and paranasal sinuses in child. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2014;13:Doc10doi: 10.3205/cto000113.
Stenner, M., & Rudack, C. (2014). Diseases of the nose and paranasal sinuses in child. GMS current topics in otorhinolaryngology, head and neck surgery, 13Doc10. https://doi.org/10.3205/cto000113
Stenner, Markus, and Rudack, Claudia. "Diseases of the nose and paranasal sinuses in child." GMS current topics in otorhinolaryngology, head and neck surgery vol. 13 (2014): Doc10. doi: https://doi.org/10.3205/cto000113
Stenner M, Rudack C. Diseases of the nose and paranasal sinuses in child. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2014 Dec 01;13:Doc10. doi: 10.3205/cto000113. eCollection 2014. PMID: 25587370; PMCID: PMC4273171.
Copy Download .nbib Format: NLM
[No title available]

Laryngo- rhino- otologie

Klimek L, Förster-Ruhrmann U, Beule AG, Chaker AM, Hagemann J, Huppertz T, Hoffmann TK, Dazert S, Deitmer T, Olze H, Strieth S, Wrede H, Schlenter W, Welkoborsky HJ, Wollenberg B, Becker S, Rudack C, Wagenmann M, Bergmann C, Bachert C.
PMID: 34592767
Laryngorhinootologie. 2021 Dec;100(12):952-963. doi: 10.1055/a-1644-4066. Epub 2021 Sep 30.

No abstract available.

Cite
Klimek L, Förster-Ruhrmann U, Beule AG, et al. Positionspapier: Empfehlungen zur Anwendung von Omalizumab bei chronischer Rhinosinusitis mit Polyposis nasi (CRSwNP) im deutschen Gesundheitssystem – Empfehlungen des Ärzteverbandes Deutscher Allergologen (AeDA) und der AGs Klinische Immunologie, Allergologie und Umweltmedizin und Rhinologie und Rhinochirurgie der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Halschirurgie (DGHNOKHC). . Laryngorhinootologie. 2021;100(12):952-963doi: 10.1055/a-1644-4066.
Klimek, L., Förster-Ruhrmann, U., Beule, A. G., Chaker, A. M., Hagemann, J., Huppertz, T., Hoffmann, T. K., Dazert, S., Deitmer, T., Olze, H., Strieth, S., Wrede, H., Schlenter, W., Welkoborsky, H. J., Wollenberg, B., Becker, S., Rudack, C., Wagenmann, M., Bergmann, C., & Bachert, C. (2021). Positionspapier: Empfehlungen zur Anwendung von Omalizumab bei chronischer Rhinosinusitis mit Polyposis nasi (CRSwNP) im deutschen Gesundheitssystem – Empfehlungen des Ärzteverbandes Deutscher Allergologen (AeDA) und der AGs Klinische Immunologie, Allergologie und Umweltmedizin und Rhinologie und Rhinochirurgie der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Halschirurgie (DGHNOKHC). . Laryngo- rhino- otologie, 100(12), 952-963. https://doi.org/10.1055/a-1644-4066
Klimek, L, et al. "Positionspapier: Empfehlungen zur Anwendung von Omalizumab bei chronischer Rhinosinusitis mit Polyposis nasi (CRSwNP) im deutschen Gesundheitssystem – Empfehlungen des Ärzteverbandes Deutscher Allergologen (AeDA) und der AGs Klinische Immunologie, Allergologie und Umweltmedizin und Rhinologie und Rhinochirurgie der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Halschirurgie (DGHNOKHC)." . Laryngo- rhino- otologie vol. 100,12 (2021): 952-963. doi: https://doi.org/10.1055/a-1644-4066
Klimek L, Förster-Ruhrmann U, Beule AG, Chaker AM, Hagemann J, Huppertz T, Hoffmann TK, Dazert S, Deitmer T, Olze H, Strieth S, Wrede H, Schlenter W, Welkoborsky HJ, Wollenberg B, Becker S, Rudack C, Wagenmann M, Bergmann C, Bachert C. Positionspapier: Empfehlungen zur Anwendung von Omalizumab bei chronischer Rhinosinusitis mit Polyposis nasi (CRSwNP) im deutschen Gesundheitssystem – Empfehlungen des Ärzteverbandes Deutscher Allergologen (AeDA) und der AGs Klinische Immunologie, Allergologie und Umweltmedizin und Rhinologie und Rhinochirurgie der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Halschirurgie (DGHNOKHC). . Laryngorhinootologie. 2021 Dec;100(12):952-963. doi: 10.1055/a-1644-4066. Epub 2021 Sep 30. German. PMID: 34592767.
Copy Download .nbib Format: NLM
Anti-inflammatory effects of ciprofloxacin in S. aureus Newman induced nasal inflammation in vitro.

Journal of inflammation (London, England)

Sachse F, von Eiff C, Becker K, Rudack C.
PMID: 18664275
J Inflamm (Lond). 2008 Jul 29;5:11. doi: 10.1186/1476-9255-5-11.

OBJECTIVES: Chronic rhinosinusitis (CRS) is a chronic inflammatory disease of the nasal mucosa. Recent studies suggest that S. aureus enterotoxins may play an etiologic role in the development of CRS. Apart from surgery and repeated courses of steroids, macrolide...

Cite
Sachse F, von Eiff C, Becker K, et al. Anti-inflammatory effects of ciprofloxacin in S. aureus Newman induced nasal inflammation in vitro. J Inflamm (Lond). 2008;5:11doi: 10.1186/1476-9255-5-11.
Sachse, F., von Eiff, C., Becker, K., & Rudack, C. (2008). Anti-inflammatory effects of ciprofloxacin in S. aureus Newman induced nasal inflammation in vitro. Journal of inflammation (London, England), 511. https://doi.org/10.1186/1476-9255-5-11
Sachse, F, et al. "Anti-inflammatory effects of ciprofloxacin in S. aureus Newman induced nasal inflammation in vitro." Journal of inflammation (London, England) vol. 5 (2008): 11. doi: https://doi.org/10.1186/1476-9255-5-11
Sachse F, von Eiff C, Becker K, Rudack C. Anti-inflammatory effects of ciprofloxacin in S. aureus Newman induced nasal inflammation in vitro. J Inflamm (Lond). 2008 Jul 29;5:11. doi: 10.1186/1476-9255-5-11. PMID: 18664275; PMCID: PMC2507710.
Copy Download .nbib Format: NLM
Metabolomic markers predictive of hepatic adaptation to therapeutic dosing of acetaminophen.

Clinical toxicology (Philadelphia, Pa.)

Sonn BJ, Heard KJ, Heard SM, D'Alessandro A, Reynolds KM, Dart RC, Rumack BH, Monte AA.
PMID: 34047639
Clin Toxicol (Phila). 2021 May 28;1-10. doi: 10.1080/15563650.2021.1925686. Epub 2021 May 28.

BACKGROUND: Drug induced liver injury (DILI) remains a prominent global issue and acetaminophen (APAP) overdose represents a common cause of hepatic injury and DILI. Transient alanine aminotransferase (ALT) elevations have been documented while adhering to recommended daily dosing. However,...

Cite
Sonn BJ, Heard KJ, Heard SM, et al. Metabolomic markers predictive of hepatic adaptation to therapeutic dosing of acetaminophen. Clin Toxicol (Phila). 2021;1-10doi: 10.1080/15563650.2021.1925686.
Sonn, B. J., Heard, K. J., Heard, S. M., D'Alessandro, A., Reynolds, K. M., Dart, R. C., Rumack, B. H., & Monte, A. A. (2021). Metabolomic markers predictive of hepatic adaptation to therapeutic dosing of acetaminophen. Clinical toxicology (Philadelphia, Pa.), 1-10. https://doi.org/10.1080/15563650.2021.1925686
Sonn, Brandon J, et al. "Metabolomic markers predictive of hepatic adaptation to therapeutic dosing of acetaminophen." Clinical toxicology (Philadelphia, Pa.) vol. (2021): 1-10. doi: https://doi.org/10.1080/15563650.2021.1925686
Sonn BJ, Heard KJ, Heard SM, D'Alessandro A, Reynolds KM, Dart RC, Rumack BH, Monte AA. Metabolomic markers predictive of hepatic adaptation to therapeutic dosing of acetaminophen. Clin Toxicol (Phila). 2021 May 28;1-10. doi: 10.1080/15563650.2021.1925686. Epub 2021 May 28. PMID: 34047639; PMCID: PMC8627525.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 31 entries